Myocardial perfusion scintigraphy: Technical innovations and evolving clinical applications

Heart

Volumn 98, Issue 5, 2012, Pages 353-359

  Anagnostopoulos, Constantinos ^a,b   Neill, Johanne ^c   Reyes, Eliana ^d   Prvulovich, Elizabeth ^c  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE; GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON; TETROFOSMIN TC 99M; THALLIUM 201;

ACUTE CORONARY SYNDROME; CARDIAC GATED IMAGING; CARDIAC RESYNCHRONIZATION THERAPY; COLLIMATOR; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE QUALITY; MYOCARDIAL HIBERNATION; MYOCARDIAL PERFUSION IMAGING; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STRESS ECHOCARDIOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84857120105     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300678     Document Type: Review

References (64)

1. Loong CY, Anagnostopoulos C. The diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging (meta-analysis). Heart 2004;90(Suppl 5):V2-9. (Pubitemid 38998268)
2. Reyes E, Anagnostopoulos C. Risk assessment by myocardial perfusion imaging in patients with suspected or known stable CAD. Nucl Med Commun 2003;25:217-20.
3. Underwood SR, Shaw LJ, Anagnostopoulos C, et al. Myocardial perfusion scintigraphy and cost effectiveness of diagnosis and management of coronary heart disease. Heart 2004;90(Suppl 5):v34-6. (Pubitemid 38998271)
4. Erlandsson K, Kacperski K, van Gramberg D, et al. Performance evaluation of DSPECT: a novel SPECT system for nuclear cardiology. Phys Med Biol 2009;54:2635-49.
5. Sharir T, Ben-Haim S, Merzon K, et al. High-speed myocardial perfusion imaging initial comparison with conventional dual detector anger camera imaging. JACC Cardiovasc Imaging 2008;1:156-63. (Pubitemid 351445405)
6. Sharir T, Slomka PJ, Hayes SW, et al. Multicentre trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and left ventricular function. J Am Coll Cardiol 2010;55:1965-74.
7. Bocher M, Blevis IM, Tuskerman L, et al. A fast cardiac gamma camera with dynamic SPECT capabilities: design, system validation and future potential. Eur J Nucl Med Mol Imaging 2010;37:1887-902.
8. Esteves FP, Raggi P, Folks RD, et al. Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicentre comparison with standard dual detector cameras. J Nucl Cardiol 2009;16:927-34.
9. Duvall WL, Croft LB, Ginsberg ES, et al. Resduced isotope dose and imaging time with a high-efficiency CZT SPECT camera. J Nuc Cardiol 2011;18(5):847-57.
10. Ben-Haim S, Kacperski K, Hain S, et al. Simultaneous dual-radionuclide myocardial imaging with a solid-state dedicated cardiac camera. Eur J Nucl Med Mol Imaging 2010;37:1710-21.
11. Ben-Haim S, Baavour R, Haroon A, et al. Assessment of myocardial perfusion reserve with dynamic myocardial perfusion SPECT. J Nucl Med 2011;52(Suppl 1):384.
12. Garcia EV, Faber TL. New trends in camera and software technology in nuclear cardiology. Cardiol Clin 2009;27:227-36, Table of Contents.
13. Corbett J, Meden J, Ficaro E. Clinical validation of attenuation corrected imaging with IQ-SPECT SPECT/CT [abstract]. J Nucl Med 2010;51(Suppl 2):P360.
14. Marcassa C, Campini R, Zoccarato O, et al. Wide beam reconstruction for half-dose or half-time cardiac gated SPECT acquisitions: optimization of resources and reduction in radiation exposure. Eur J Nucl Med Mol Imaging 2011;38:499-508.
15. Valenta I, Trreyer V, Husmann L, et al. New reconstruction algorithm allows shortened acquisition time for myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging 2010;37:750-7.
16. Bateman TM, Heller GV, McGhie AI, et al. Multicenter investigation comparing a highly efficient half-time stress-only attenuation correction approach against standard rest-stress Tc-99m SPECT imaging. J Nucl Cardiol 2009;16:726-35.
17. Chen J, Boogers MM, Bax JJ, et al. The use of nuclear imaging for cardic resynchronisation therapy. Curr Cardiol Rep 2010;12:185-91.
18. Boogers MM, Van Kriekinge SD, Henneman MM, et al. Quantitative gate SPECTderived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy. J Nucl Med 2009;50:718-25.
19. Pazhenkottil AP, Herzog BA, Husmann L, et al. Non-invasive assessment of coronary artery disease with CT coronary angiography and SPECT: a novel dose-saving fast-track algorithm. Eur J Nucl Med Mol Imaging 2010;37:522-7.
20. Taillefer R, Ahlberg AW, Masood Y, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003;42:1475-83. (Pubitemid 37267293)
21. Reyes E, Stirrup J, Roughton M, et al. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective & beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study. J Nucl Med 2010;51:1036-43.
22. Reyes E, Loong CY, Harbinson M, et al. High dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. J Am Coll Cardiol 2008;52:2008-16.
23. Iskandrian AE, Bateman TM, Belardinelli L, et al ADVANCE MPI Investigators. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trials. J Nucl Cardiol 2007;14:645-58. (Pubitemid 47355078)
24. 2aagonist regadenoson versus adenosine in myocardial perfusion imaging: integrated ADVANCE-MPI trial results. J Am Coll Cardiol Img 2008;1:307-16.
25. 2Areceptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol 2008;15:329-36.
26. Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2Aagonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol 2008;15:319-28.
27. Pazhenkottil AP, Buechel RR, Husmann L, et al. Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging. Heart 2011;97:33-7.
28. Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012-24.
29. Shaw LJ, Berman DS, Maron DJ, et al COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91. (Pubitemid 351365675)
30. Skinner JS, Smeeth L, Kendall JM, et al. The Chest Pain Guideline Development Group for the National Institute of Clinical Excellence. Chest pain of recent onset: Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Heart 2010;96(12):974-8.
31. Gibbons RJ, Abrams J, Chatterjee K, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee on the Management of Patients with Chronic Stable Angina. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003;107:149-58. (Pubitemid 36070948)
32. Fox K, Garcia MA, Ardissino D, et al Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81. (Pubitemid 43998110)
33. Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/ SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging. J Am Coll Cardiol 2009;53:2201-29.
34. Greenland P, Alpert JS, Beller GA, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. Circulation 2010;122:e584-636.
35. Perrone-Filardi P, Achenbach S, Möhlenkamp S, et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease. Eur Heart J 2011;32:1986-93, 1993a, 1993b.
36. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation 2009;120:e169-276.
37. Hendel RC, Abbott BG, Bateman TM, et al. TEMENT The role of radionuclide myocardial perfusion imaging for asymptomatic individuals. J Nucl Cardiol 2011;18:3-15.
38. Amsterdam EA, Kirk JD, Bluemke DA, et al American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation 2010;122:1756-76.
39. Brindis RG, Douglas PS, Hendel RC, et al. ACCF/ASNC. Appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol 2005;46:1587-605. (Pubitemid 41446203)
40. Kapetanopoulos A, Heller GV, Selker HP, et al. Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ERASE Chest Pain) trial. J Nucl Cardiol 2004;11:570-7. (Pubitemid 39341802)
41. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:E1-211.
42. Brown KA, Heller GV, Landin RS, et al. Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060-6. (Pubitemid 29532056)
43. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Eur Heart J 2007;28:1598-660. (Pubitemid 47227122)
44. Wright RS, Anderson JL, Adams CD, et al. ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011;57:e215-367.
45. Mahmarian JJ, Dakik HA, Filipchuk NG, et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol 2006;48:2458-67. (Pubitemid 44881230)
46. Berti V, Sciagrà R, Acampa W, et al. Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction. Eur J Nucl Med Mol Imaging 2011;38:1124-31.
47. Hunt SA, Abraham WT, Chin MH, et al. Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-90.
48. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-55.
49. Schinkel AF, Bax JJ, Poldermans D, et al. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007;32:375-410. (Pubitemid 46881171)
50. Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364:1617-25.
51. Schepis T, Gaemperli O, Koepfli P, et al. Added value of coronary artery calcium score as an adjunct to gated SPECT for the evaluation of coronary artery disease in an intermediate-risk population. J Nucl Med 2007;48:1424-30. (Pubitemid 47397389)
52. Ghadri JR, Pazhenkottil AP, Nkoulou RN, et al. Very high coronary calcium score unmasks obstructive coronary artery disease in patients with normal SPECT MPI. Heart 2011;97:998-1003.
53. Blankstein R, Di Carli MF. Integration of coronary anatomy and myocardial perfusion imaging. Nat Rev Cardiol 2010;7:226-36.
54. Flotats A, Knuuti J, Gutberlet M, et al. Cardiovascular Committee of the EANM, the ESCR and the ECNC. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging 2011;38:201-12.
55. Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol 2009;54:1872-82.
56. van Werkhoven JM, Schuijf JD, Gaemperli O, et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 2009;53:623-32.
57. Pazhenkottil AP, Nkoulou RN, Ghadri JR, et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J 2011;32:1465-71.
58. Gaemperli O, Bengel FM, Kaufmann PA. Cardiac hybrid imaging. Eur Heart J 2011;32:2100-8.
59. Williams MC, Reid JH, McKillop G, et al. Cardiac and coronary CT comprehensive imaging approach in the assessment of coronary heart disease. Heart 2011;97:1198-205.
60. Dodla S, Xie F, Smith M, et al. Real-time perfusion echocardiography during treadmill exercise and dobutamine stress testing. Heart 2010;96:220-5.
61. Yoshinaga K, Tamakai N, Ruddy TD, et al. Evaluation of myocardial perfusion. In: Wahl RL, Beanlands RSB, eds. Principles and practice of PET and PET/CT. Philadelphia, PA, 2009:541-65.
62. Yu M, Nekolla SG, Schwaiger M, et al. The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease. Semin Nucl Med 2011;41:305-13.
63. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed contrast enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-8.
64. Watkins S, McGeoch R, Lyne J, et al. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation 2009;120:2207-13.